It's a personal calculation. Right now my primary investment is non-biotech and has a very tight share structure... Since I am not taking anything out of the account and I have a very high level of confidence that it will be a dividend paying stock for my grand nieces I am focusing on accumulating that specific stock.
Others are free to make other decisions based on their own personal priorities.
I am watching the stock because I do believe it has potential - just not investing at this time.
If NWBO earns the approval type described as agnostic, then theoretically, DCVAX - D could enjoy a near simultaneous approval for solid tumors. If true, shareholders could enjoy a top line valuation in an abbreviated timeline.
Market Data 
Markets 
AI
